1. Home
  2. SQFT vs PRFX Comparison

SQFT vs PRFX Comparison

Compare SQFT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Presidio Property Trust Inc.

SQFT

Presidio Property Trust Inc.

HOLD

Current Price

$1.42

Market Cap

3.2M

Sector

Real Estate

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.94

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQFT
PRFX
Founded
1999
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.6M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
SQFT
PRFX
Price
$1.42
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.2K
185.3K
Earning Date
05-13-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,814,708.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.58
52 Week High
$10.47
$5.39

Technical Indicators

Market Signals
Indicator
SQFT
PRFX
Relative Strength Index (RSI) 21.69 39.01
Support Level $1.32 $0.83
Resistance Level $3.09 $1.25
Average True Range (ATR) 0.13 0.09
MACD -0.07 0.01
Stochastic Oscillator 6.60 0.31

Price Performance

Historical Comparison
SQFT
PRFX

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: